Profile data is unavailable for this security.
About the company
Stille AB is a Sweden-based company engaged in the development, manufacture, and marketing of technical medical equipment. The product portfolio is divided into two business lines. The Surgery business area develops, produces and markets handcrafted, forged surgical instruments for all fields of open surgery, with an emphasis on cardiovascular surgery, and reconstructive and aesthetic plastic surgery. Its products include scissors, forceps, artery forceps, needle holders and clamps, among others. The Patient Positioning area develops and manufactures two main groups of procedure-specific specialized tables for cardiovascular surgery and gynecology, urology and urodynamic examinations. As of December 31, 2011, the Company had two wholly owned subsidiaries, Stille Surgical Inc. and Stille Incentive AB. As of December 30, 2011, the it's largest shareholder was Linc Invest AB (39.81%). On September 2, 2013, the Company sold its business unit, Sonesta, to ADDvise Lab Solutions publ AB.
- Revenue in SEK (TTM)552.55m
- Net income in SEK40.41m
- Incorporated1984
- Employees208.00
- LocationStille ABEkbacken 11TORSHAELLA 644 30SwedenSWE
- Phone+46 858858000
- Fax+46 858858005
- Websitehttps://www.stille.se/
More ▼
Mergers & acquisitions
| Acquired company | STIL:STO since announced | Transaction value |
|---|---|---|
| Surgical Holdings Ltd | -30.14% | 10.58m |
Data delayed at least 15 minutes, as of Feb 09 2026 17:00 GMT.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Senzime AB (publ) | 89.71m | -120.62m | 736.55m | 50.00 | -- | 2.11 | -- | 8.21 | -0.8672 | -0.8672 | 0.6394 | 2.22 | 0.234 | 1.73 | 5.99 | 1,794,120.00 | -31.47 | -35.09 | -34.04 | -37.52 | 41.86 | 8.75 | -134.46 | -400.65 | 4.30 | -7.70 | 0.0399 | -- | 63.55 | 54.18 | 11.50 | -- | 40.12 | -- |
| Omda AS | 442.21m | -28.19m | 803.93m | 260.00 | -- | 25.36 | 29.13 | 1.82 | -1.51 | -1.51 | 23.59 | 1.63 | 0.6793 | 26.59 | 21.70 | 1,772,075.00 | -4.33 | -5.14 | -5.39 | -6.63 | 93.69 | 91.09 | -6.37 | -10.32 | 0.6483 | 0.5281 | 0.9359 | -- | 3.45 | 15.80 | -163.95 | -- | -15.57 | -- |
| Gentian Diagnostics ASA | 160.64m | 39.83m | 830.02m | 63.00 | 21.14 | 4.41 | 17.21 | 5.17 | 2.73 | 2.73 | 11.07 | 13.10 | 0.8181 | 1.63 | 7.83 | 2,738,365.00 | 20.29 | -2.99 | 22.99 | -3.36 | 55.06 | 44.66 | 24.80 | -5.84 | 4.16 | -- | 0.0094 | -- | 12.52 | 25.96 | 525.37 | -- | 22.08 | -- |
| Optomed Oyj | 185.34m | -61.26m | 885.26m | 112.00 | -- | 3.76 | -- | 4.78 | -0.2915 | -0.2915 | 0.8803 | 1.03 | 0.5847 | 2.40 | 5.47 | 151,147.80 | -19.33 | -14.59 | -23.47 | -17.41 | 64.64 | 65.60 | -33.05 | -31.36 | 1.60 | -20.89 | 0.1221 | -- | -0.3974 | 0.084 | -22.72 | -- | 8.10 | -- |
| Nexstim Oyj | 107.32m | -3.02m | 976.81m | 40.00 | -- | 28.69 | 138.02 | 9.10 | -0.042 | -0.042 | 1.47 | 0.4426 | 0.8553 | 0.5613 | 4.66 | 251,616.80 | -2.40 | -12.40 | -4.17 | -20.76 | 94.36 | 95.09 | -2.81 | -16.29 | 1.08 | 0.7835 | 0.6002 | -- | 20.55 | 21.14 | 32.79 | -- | 15.13 | -- |
| Sedana Medical AB (publ) | 197.61m | -40.65m | 987.41m | 117.00 | -- | 1.09 | -- | 5.00 | -0.4092 | -0.4092 | 1.99 | 9.14 | 0.2012 | 1.46 | 9.47 | 2,670,406.00 | -4.14 | -4.90 | -4.34 | -5.16 | 70.47 | 68.32 | -20.57 | -30.26 | 3.28 | -21.90 | 0.0045 | -- | 16.17 | 20.06 | 82.09 | -- | 26.45 | -- |
| C Rad AB | 457.70m | 23.25m | 1.04bn | 107.00 | 45.65 | 3.00 | 30.61 | 2.27 | 0.6922 | 0.6922 | 13.58 | 10.53 | -- | -- | -- | 4,623,273.00 | -- | 8.44 | -- | 11.73 | 51.45 | 45.00 | 5.08 | 8.28 | 2.98 | 3.31 | 0.0252 | 0.00 | 10.45 | 17.96 | 58.88 | -- | -9.15 | -- |
| ADDvise Group AB (publ) | 1.62bn | 4.30m | 1.04bn | 615.00 | 19.91 | 0.9402 | 9.37 | 0.6416 | 0.0864 | 0.0864 | 3.44 | 1.83 | 0.5167 | 7.91 | 4.96 | 2,534,790.00 | 0.1399 | 3.41 | 0.174 | 4.28 | 39.91 | 46.52 | 0.2708 | 6.06 | 0.7562 | 1.62 | 0.5251 | 0.4389 | 21.68 | 36.71 | -13.04 | 85.85 | 52.63 | -- |
| Paxman AB (publ) | 295.08m | 4.92m | 1.05bn | 142.00 | 163.24 | 2.45 | 42.50 | 3.55 | 0.2757 | 0.2757 | 14.26 | 18.38 | 0.8486 | 3.45 | 4.71 | 2,810,305.00 | 1.37 | 0.8426 | 1.60 | 1.20 | 67.34 | 68.75 | 1.61 | 0.7966 | 4.07 | 1.71 | 0.0245 | 0.00 | 20.41 | 24.30 | 382.55 | 70.92 | -3.73 | -- |
| BICO Group AB | 1.51bn | -1.26bn | 1.20bn | 586.00 | -- | 0.6774 | -- | 0.7975 | -17.83 | -9.68 | 21.34 | 25.67 | 0.3269 | 3.30 | 3.65 | 2,074,793.00 | -27.41 | -- | -35.79 | -- | 36.91 | -- | -83.83 | -- | 1.13 | -- | 0.4174 | -- | -3.19 | -- | 88.56 | -- | -- | -- |
| Surgical Science Sweden AB | 975.04m | 69.83m | 1.26bn | 328.00 | 18.01 | 0.2924 | 8.64 | 1.29 | 1.37 | 1.37 | 19.11 | 84.27 | 0.2051 | 1.72 | 7.09 | 3,558,537.00 | 1.47 | 3.91 | 1.55 | 4.18 | 66.61 | 68.94 | 7.16 | 21.55 | 3.44 | -- | 0.0004 | 0.00 | 0.1398 | 54.17 | -43.73 | 59.89 | 39.76 | -- |
| Stille AB | 552.55m | 40.41m | 1.35bn | 208.00 | 33.33 | 1.95 | 15.21 | 2.44 | 4.50 | 4.50 | 62.09 | 77.10 | 0.531 | 1.55 | 7.66 | 3,891,176.00 | 3.88 | 6.20 | 4.55 | 7.11 | 52.45 | 47.21 | 7.31 | 9.48 | 1.87 | -- | 0.00 | 16.29 | 93.27 | 29.47 | 118.44 | 20.53 | 13.88 | -- |
| Genovis AB | 116.63m | 21.19m | 1.35bn | 36.00 | 63.41 | 5.13 | 41.92 | 11.58 | 0.3225 | 0.3225 | 1.78 | 3.99 | 0.3404 | -- | -- | 3,644,719.00 | 6.18 | 15.62 | 6.57 | 17.56 | 90.28 | 88.86 | 18.16 | 25.11 | -- | -- | 0.2171 | 0.00 | -17.62 | 16.58 | -46.48 | 28.08 | -1.42 | -- |
| Nordhealth As | 534.76m | -113.33m | 1.45bn | 450.00 | -- | 3.65 | -- | 2.70 | -1.54 | -1.54 | 7.26 | 9.43 | 0.6188 | -- | 8.10 | 1,397,347.00 | -13.11 | -- | -14.99 | -- | 82.95 | -- | -21.19 | -- | -- | -- | 0.00 | -- | 24.03 | -- | 31.06 | -- | -- | -- |
| Carasent AB (publ) | 328.93m | -18.60m | 1.74bn | 196.00 | -- | 2.04 | 39.28 | 5.28 | -0.268 | -0.268 | 4.64 | 11.78 | 0.3226 | -- | 7.35 | 1,652,936.00 | -1.82 | -- | -2.04 | -- | 84.59 | -- | -5.65 | -- | -- | -- | 0.0412 | -- | 12.27 | -- | 9.46 | -- | -- | -- |
| Detection Technology Oyj | 1.12bn | 95.30m | 1.87bn | 494.00 | 19.60 | 2.41 | 16.27 | 1.66 | 0.6097 | 0.6097 | 7.19 | 4.96 | 1.18 | 2.58 | 3.19 | 216,295.30 | 10.02 | 8.54 | 12.22 | 10.73 | 46.33 | 47.22 | 8.50 | 7.85 | 3.05 | 38.10 | 0.00 | 60.32 | 3.58 | 0.9636 | 101.97 | -2.29 | -11.31 | 5.64 |
Data as of Feb 09 2026. Currency figures normalised to Stille AB's reporting currency: Swedish Krona SEK
25.32%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Lannebo Kapitalf�rvaltning AB (Sweden)as of 23 Dec 2025 | 692.22k | 7.70% |
| SEB Funds ABas of 23 Dec 2025 | 451.05k | 5.02% |
| Aktia Bank Plc (Investment Management)as of 23 Dec 2025 | 360.35k | 4.01% |
| Joh. Berenberg, Gossler & Co. KG (Investment Management)as of 31 Jan 2025 | 245.37k | 2.73% |
| Fondita Fund Management Co. Ltd.as of 23 Dec 2025 | 180.00k | 2.00% |
| Schroder Investment Management (Europe) SA (Finland)as of 30 Jun 2025 | 160.36k | 1.79% |
| Atle Fund Management ABas of 31 Dec 2024 | 90.44k | 1.01% |
| ODIN Forvaltning AS (Sweden)as of 30 Jun 2025 | 40.10k | 0.45% |
| Philippe Hottinguer & Cie Gestion SASas of 30 Jun 2025 | 29.00k | 0.32% |
| Amundi Asset Management SASU (Investment Management)as of 31 Dec 2025 | 25.82k | 0.29% |
More ▼
Data from 30 Jun 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
